Latest news
Loading news…
Foldrx Pharmaceuticals
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Cambridge, Massachusetts, United States Founded 2003 11-50 employees For Profit
FoldRx Pharmaceuticals is focused on discovering and developing disease-modifying drug therapies for protein misfolding diseases.
Foldrx Pharmaceuticals was acquired by Pfizer in 2010.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
3
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 0
- Active products
- 2
- IT spend
- $9M
Company Info
- Founded
- 2003
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Diversity spotlight
- Women Founded
- Exit date
- Sep 1, 2010
- Closed
- Sep 1, 2010
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 4
- Trend (90d)
- 0
3
professional contacts at Foldrx Pharmaceuticals
Contact execs at Foldrx Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Foldrx Pharmaceuticals
Loading news…
FAQs about Foldrx Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.